Lung cancer drug vizimpro under Real-World watch in korea

This study looked at the safety and effectiveness of the drug Vizimpro in 188 adults with advanced lung cancer who had specific gene mutations. It was an observational study, meaning patients received their normal treatment and researchers simply collected data on side effects and tumor response. The goal was to confirm the drug's real-world performance after it was already approved for use in Korea.